Have a Claim?

Click here for a confidential contact or call:


November 3, 2014

Posted  January 22, 2016

California-based medical diagnostics and life sciences manufacturing company Bio-Rad Laboratories Inc. agreed to pay $55M million to settle allegations it violated the Foreign Corrupt Practices Act (FCPA) by falsifying its books and records and failing to implement adequate internal controls in connection with sales it made in Russia and for making illegal bribes in connection with sales it made in Russia, Thailand and Vietnam. The company will pay $14.35M to the DOJ and $40.7M to the SEC.Whistleblower Insider

Tagged in: FCPA,